GET DAILY SIGNALSHyperion DeFi (HYPD): Potential +300% Upside to Reach $10 Target
Key Takeaways
- The central $10 stock price target represents the rounded average of two analyst estimates: $11.20 from Cantor Fitzgerald and $8.45 from Chardan Capital, for a mean of $9.83.
- At the latest close of $2.49, the stock sits well below this level, pointing to roughly 300% upside potential.
- Analyst targets range from $8.45 to $11.20, showing meaningful differences in how quickly the crypto-treasury strategy might translate into value.
- Both firms maintain Buy or Overweight ratings, yet coverage remains limited to just two providers, making the consensus less statistically reliable than for larger companies.
- Positive elements include Hyperliquid ecosystem exposure, raised gross-profit guidance, and a $20 million share repurchase program; key risks involve limited revenue, ongoing losses, and high volatility.
- Additional details on Major News, Today's Price Move, the Forecast, and Earnings are available on dedicated pages.
Analyst Consensus on Price Targets
Only two current analyst price targets cover HYPD. Cantor Fitzgerald lifted its target to $11.20 from $7.10 on Sept. 10, 2026, while keeping an Overweight rating and highlighting crypto-market momentum along with the view that digital-asset drawdowns had likely ended. Chardan Capital moved its target to $8.45 from $7.30 on Sept. 8, 2026, retaining a Buy rating and referencing higher full-year adjusted gross-profit guidance plus the new $20 million buyback. The simple average of these figures comes to $9.83, which rounds to the $10 central target. The broad $8.45-to-$11.20 spread illustrates real differences in valuation assumptions even among bullish analysts, and with coverage this thin the average serves more as an indicative benchmark than a comprehensive market view. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Position and Upside Potential
Closing at $2.49, HYPD would require an advance of about 300% to hit $10, or roughly 295% to reach the $9.83 mean. That remains a substantial move for a company reporting trailing twelve-month revenue near $1.4 million and a net loss of approximately $17.9 million. The shares trade below the 52-week high of $6.48 within a range of $2.34 to $6.48 and carry a beta around 2.7, underscoring elevated sensitivity to broader market shifts. Progress toward the target will depend mainly on converting the HYPE token treasury and ecosystem participation into recurring revenue, alongside overall cryptocurrency sentiment. The upcoming earnings release on Nov. 12, 2026, should provide an important update.
Factors That Could Drive the Stock Higher
Exposure to the Hyperliquid blockchain ecosystem stands out as the primary tailwind, offering leveraged participation in a potential crypto recovery. Management has increased full-year adjusted gross-profit guidance, and Chardan has pointed to ecosystem rewards, DeFi monetization, and yield enhancement as second-half contributors. The $20 million buyback further signals confidence and could provide share-price support. A sustained upmove in digital assets would likely boost both sentiment and treasury value. From what I see, these elements together form the core bullish scenario.
Risks That Might Hold It Back
Several meaningful obstacles remain. Revenue stays minimal, the company continues to report losses, and the most recent quarterly results missed expectations on both earnings and revenue. The business model ties closely to volatile crypto markets, so any renewed downturn could pressure the treasury and investor confidence. Thin trading volume, a limited public float, and the wide analyst range add further uncertainty. Valuation pressure, slower monetization, or weakness in the Hyperliquid ecosystem could each keep the shares well below the target.
Technical Levels to Watch
The 52-week low at $2.34 offers the clearest near-term support, while the prior high of $6.48 represents the initial major resistance before any sustained push toward $10. A roughly 35% decline over the past month combined with the high beta suggests any recovery would need to rest on sustained buying interest rather than a brief rebound.
What to Monitor Going Forward
Analyst targets generally reflect a 12-month horizon, though neither firm has specified an exact timeline. Investors should follow the Nov. 12, 2026 earnings report and any accompanying guidance, potential analyst updates or new coverage, cryptocurrency and Hyperliquid ecosystem developments, the pace of buyback activity, and shifts in the HYPE token treasury value. Broader macro conditions influencing risk appetite and digital-asset prices will also remain central.
Using AI Tools to Track Volatile Names
In my own process I occasionally reference Tickeron’s AI Daily Buy/Sell Signals to monitor names like this one more systematically. The tool applies artificial intelligence across thousands of stocks and ETFs to generate Buy, Sell, or Hold signals based on technical behavior and market shifts. For a thinly covered, high-volatility stock, this kind of ongoing data-driven input can help surface opportunities and track trend changes alongside traditional research.
Final Assessment
Whether HYPD can reach $10 rests on a target derived from just two analyst estimates averaging $9.83 within an $8.45-to-$11.20 range. Achieving that level would require an advance of roughly 300% from the $2.49 close. The constructive case centers on Hyperliquid exposure, improved gross-profit guidance, and the buyback, while the more cautious view highlights minimal revenue, persistent losses, a recent earnings miss, and crypto-linked volatility. With limited analyst coverage and a high-beta profile, the target functions best as a scenario-based, longer-term reference point rather than a near-term expectation. The next earnings report should offer the clearest near-term indication of whether fundamentals can begin to narrow the gap.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HYPD sees MACD Histogram just turned negative
HYPD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 05, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 38 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HYPD as a result. In 63 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
HYPD moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HYPD crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HYPD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HYPD entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HYPD's RSI Indicator exited the oversold zone, 24 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 50-day moving average for HYPD moved above the 200-day moving average on October 19, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where HYPD advanced for three days, in 186 of 226 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
HYPD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.380) is normal, around the industry mean (3.482). P/E Ratio (-0.664) is within average values for comparable stocks, (-1.183). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (25.707) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. HYPD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HYPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a company which delivers sight saving therapies
Industry Biotechnology
Advertisement